CorMedix (CRMD) Asset Utilization Ratio (2016 - 2025)
CorMedix's (CRMD) quarterly Asset Utilization Ratio came in at 0.4 in Q4 2025, down 10.75% year-on-year from 0.44 in Q4 2024, and down 7.45% quarter-over-quarter from 0.43 in Q3 2025.
CorMedix (CRMD) Asset Utilization Ratio (2016 - 2025) Analysis & Trends
CorMedix has disclosed Asset Utilization Ratio across 9 years of filings, most recently posting 0.4 for Q4 2025.
- Asset Utilization Ratio for Q4 2025 came in at 0.4, down 10.75% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.4 (down 10.75% YoY), and the FY2025 annual result was 0.66, up 52.44% from the prior year.
- Asset Utilization Ratio came in at 0.4 for Q4 2025 at CorMedix, down from 0.43 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.62 in Q1 2025 to a low of 0.0 in Q4 2022.
- The 4-year median for Asset Utilization Ratio is 0.0 (2021), against an average of 0.18.
- Across the five-year window, Asset Utilization Ratio slumped 62.43% in 2021 and jumped 4297.05% in 2025, its largest moves.
- CorMedix's Asset Utilization Ratio stood at 0.0 in 2021, then tumbled by 60.16% to 0.0 in 2022, then jumped by 41923.06% to 0.44 in 2024, then dropped by 10.75% to 0.4 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.4 (Q4 2025), 0.43 (Q3 2025), and 0.6 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 0.55 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.62 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |